Phase 1 Carcinoma, Hepatocellular Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaUnresectable Hepatocellular Carcinoma+4 more
Pfizer138 enrolled11 locationsNCT07227012
Recruiting
Phase 1
A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
Carcinoma, HepatocellularNeoplasms
Aptamer Sciences, Inc.70 enrolled4 locationsNCT06687941
Recruiting
Phase 1Phase 2
A Study of PTX-9908 Injection for Non-resectable HCC with TACE
Carcinoma, Hepatocellular
TCM Biotech International Corp.50 enrolled1 locationNCT03812874
Recruiting
Phase 1Phase 2
ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma
Carcinoma, Hepatocellular
Abivax S.A.48 enrolled2 locationsNCT03897543